Epidermal Growth Factor Receptor (EGFR) (C-Term) Peptide
EGFR
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all EGFR products
- EGFR (Epidermal Growth Factor Receptor (EGFR))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LNPAPSRDPH YQDPHSTAVG NPEYLNTVQP TCVNSTFDSP AHWAQKGSHQ
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- EGFR Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EGFR (Epidermal Growth Factor Receptor (EGFR))
- Background
-
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer.
Alias Symbols: ERBB, HER1, mENA, ERBB1, PIG61, NISBD2
Protein Size: 1210 - Gene ID
- 1956
- NCBI Accession
- NM_005228, NP_005219
- UniProt
- P00533
-
You are here:
